CorVel Corporation — Form 10-Q Summary
Reporting period: The filing covers the quarter and nine months ended December 31, 2017 (CorVel fiscal 2018 third quarter). This conflicts with the request metadata identifying “2016 Q3”; the filing itself is for 2017 Q3. Financial amounts are in U.S. dollars.
Business context and results
CorVel provides managed-care services, principally network solutions and patient management, to workers’ compensation, auto insurance, and group-health payors. It reports one operating segment. For the quarter, patient management generated 56.4% of revenue and network solutions 43.6%.
| Metric | Three months ended Dec. 31 | Nine months ended Dec. 31 |
|---|---|---|
| Revenue, 2017 (change from 2016) | $140.7 million (+9.6%) | $414.8 million (+7.7%) |
| Gross profit, 2017 (change) | $25.6 million (roughly flat) | $80.1 million (+3.9%) |
| Gross margin, 2017 (2016) | 18.2% (19.9%) | 19.3% (20.0%) |
| Income before taxes, 2017 | $10.1 million | $36.3 million |
| Net income, 2017 (change) | $9.6 million (+35.7%) | $26.7 million (+24.4%) |
| Diluted EPS, 2017 (2016) | $0.50 ($0.36) | $1.41 ($1.09) |
| Operating cash flow, 2017 (2016) | Not provided for quarter | $49.9 million ($36.5 million) |
Financial position, liquidity and cash flow
- At December 31, cash and cash equivalents were $53.6 million, up $25.0 million from March 31. Working capital was $56.7 million, compared with $38.8 million at fiscal year-end.
- Nine-month investing cash outflow was $16.3 million, primarily property and equipment purchases; financing cash outflow was $8.6 million, including $11.2 million of treasury-stock purchases.
- The company reported no debt or revolving loans outstanding. Its renewed revolving facility allows up to $10 million of borrowing and expires in September 2018; the company was in covenant compliance. Separate letters of credit totaled $4.5 million.
- Accrued liabilities rose to $93.0 million from $73.5 million, including higher customer deposits, payroll-related accruals, and deferred revenue. Operating cash flow benefited from the timing of bonus payments and increased deferred revenue.
- Contractual obligations totaled $66.9 million, including $57.8 million of operating lease payments and a $5.79 million building purchase commitment. Management expected to fund the building purchase with existing cash.
Material changes and unusual items
- Quarterly revenue growth was led by patient management, up 11.2%, including higher TPA services, and network solutions, up 7.7%. Management cited lower-margin TPA growth and weaker case-management margins as factors in the decline in gross margin.
- Quarterly cost of revenue rose 12.0%, faster than revenue, reflecting higher field salaries and headcount, pharmacy costs, and self-insured group medical costs. The company cited a $2.0 million quarterly increase in group medical costs; for the nine-month period, it cited $2.5 million, including several large claims.
- The Tax Cuts and Jobs Act reduced the federal corporate tax rate. CorVel recorded a $3.0 million benefit from remeasuring deferred tax balances; the quarterly effective tax rate was 5.0%, versus 38.4% a year earlier. Nine-month effective tax rates were 24.5% and 38.3%, respectively. The tax benefit materially supported reported earnings growth.
- The company recorded a further $1.169 million impairment of its private-equity investment during the nine months ended December 31, 2017. Management attributed higher quarterly general and administrative expense in part to this impairment and increased performance-based stock compensation.
- Share repurchases reduced weighted-average shares. CorVel repurchased 249,245 shares for $11.2 million during the nine months; there were no repurchases during the December quarter.
Outlook, commentary and risks
- No specific revenue or earnings guidance was provided. Management expected a combined federal and state effective tax rate of approximately 25%–26% for the fiscal year beginning April 1, 2018, assuming results consistent with recent trends; the company was still assessing the tax law’s final effects.
- Management said cash from operations, option exercises, and the credit facility should be adequate for obligations and planned activities for at least 12 months. This is a forward-looking assessment, not a guarantee.
- Management noted a long-term decline in U.S. workplace injury rates, which could reduce claims and medical spending subject to review. Other cited risks include competition and customer insourcing, lower outsourced claim volumes, wage and benefit costs, staffing availability, regulation, litigation, cybersecurity and service interruptions, and execution of software and growth initiatives.
- CorVel expects the new lease accounting standard, effective for it April 1, 2019, to have a material effect on the balance sheet. It anticipated no significant financial-statement impact from the new revenue standard based on its review to date, but could not yet estimate the effect on non-standard contracts.
- Management considered ordinary-course litigation not likely to result in material payments. Disclosure controls were deemed effective; the CFO transition took effect January 1, 2018.
Investor verification points
- Confirm the reporting-period mismatch: the supplied metadata says 2016 Q3, while this filing reports the quarter ended December 31, 2017.
- Separate underlying operating performance from the $3.0 million tax-remeasurement benefit when assessing earnings and EPS growth.
- Track gross-margin pressure, especially TPA mix, case-management margins, staffing costs, and medical claims costs.
- Assess the quality and sustainability of operating cash flow, including the contribution from accrued liabilities and deferred revenue.
- Review the private-equity investment’s remaining carrying value and impairment exposure, as well as the building purchase and lease commitments.
- Monitor the company’s tax-rate estimate, credit-facility renewal, and the expected balance-sheet effect of lease-standard adoption.